| Literature DB >> 30886702 |
Westyn Branch-Elliman1,2,3, Steven D Pizer4,5, Elise A Dasinger6, Howard S Gold3,7, Hassen Abdulkerim2, Amy K Rosen2,8, Martin P Charns2, Mary T Hawn9,10, Kamal M F Itani11,3,8, Hillary J Mull2,8.
Abstract
Background: Guidelines recommend discontinuation of antimicrobial prophylaxis within 24 h after incision closure in uninfected patients. However, how facility and surgical specialty factors affect the implementation of these evidence-based surgical prophylaxis guidelines in outpatient surgery is unknown. Thus, we sought to measure how facility complexity, including ambulatory surgical center (ASC) status and availability of ancillary services, impact adherence to guidelines for timely discontinuation of antimicrobial prophylaxis after outpatient surgery. A secondary aim was to measure the association between surgical specialty and guideline compliance.Entities:
Keywords: Ambulatory surgery; Antimicrobial stewardship; Prophylaxis; Quality improvement; Surgical quality
Year: 2019 PMID: 30886702 PMCID: PMC6404270 DOI: 10.1186/s13756-019-0503-9
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Fig. 1Identification of Study Sample from FY16–17 Outpatient Encounters in VA Facilities with Surgical Services
Comparison of Rates of Prolonged Prophylactic Antimicrobial Use across Surgical Specialties in VA ASCs vs. HOPDs
| Surgery Type | Total | HOPD | ASC | |||
|---|---|---|---|---|---|---|
| Total | Total | |||||
| Eye | 67,778 (25.1%) | 254 (0.4%) | 64,034 | 243 (0.38%) | 3744 | 11 (0.29%) |
| Genitourinary | 38,507 (14.3%) | 5288 (13.7%) | 37,023 | 5061 (13.67%) | 1484 | 227 (15.30%) |
| Orthopedics | 17,221 (6.4%) | 667 (3.9%) | 16,712 | 651 (3.90%) | 509 | 16 (3.14%) |
| Ear/Nose/Throat | 15,661 (5.8%) | 1419 (9.1%) | 15,054 | 1381 (9.17%) | 607 | 38 (6.26%)* |
| General Surgery | 13,930 (5.2%) | 84 (0.6%) | 13,616 | 75 (0.55%) | 314 | 9 (2.87%)** |
Note: Chi-square tests compared the rates of prolonged post-operative antimicrobial use by specialty in hospital outpatient departments (HOPDs) versus ambulatory surgical centers (ASCs) in VA FY16–17 outpatient surgeries. * = p < 0.05, ** = p < 0.001
Patient, Procedure and Facility Characteristics among FY16–17 VA Outpatient Surgeries in 5 High-Volume Surgical Specialties with and without Prolonged Prophylactic Antimicrobials
| Variable | Total (%) | With Prolonged Antimicrobial Exposure, |
|---|---|---|
| Total | 153,097 | 7712 (5.0%) |
| Patient Characteristics | ||
| Female | 7623 (5%) | 424 (5%)* |
| White | 121,169 (79%) | 6191 (80%)* |
| Age, years (std. dev) | 67.6 (11.7) | 65.2 (12.5)** |
| Comorbidity index, score (std. dev) | 2.5 (6.5) | 2.5 (6.3) |
| Procedure Characteristics | ||
| Relative value unit (std. dev) | 5.4 (3.9) | 5.2 (3.5)** |
| Eye | 67,778 (44%) | 254 (3%)** |
| Genitourinary | 38,507 (25%) | 5288 (69%)** |
| Orthopedics | 17,221 (11%) | 667 (9%)** |
| Ear/Nose/Throat | 15,661 (10%) | 1419 (18%)** |
| General Surgery | 13,930 (9%) | 84 (1%)** |
| Facility Characteristics | ||
| ASC | 6658 (4%) | 301 (4%)* |
| Standard HOPD | 3257 (2%) | 218 (3%)** |
| Intermediate HOPD | 24,989 (16%) | 1839 (24%)** |
| Complex HOPD | 118,193 (77%) | 5354 (69%)** |
Note: Comparisons are chi-square tests for bivariates and two-tailed t-tests for continuous variables. Symbols indicate significance: **p-value< 0.001; *p-value< 0.05
Top 25 Surgical Procedures among 153,097 VA Outpatient Surgeries from FY16–17 with and without Prolonged Prophylactic Antimicrobials*
| Surgical Specialty | Procedure and CPT Codes | With Prolonged Antimicrobial Exposure, | |
|---|---|---|---|
| Eye | CPT: 67028, injection eye drug | 23,987 (16%) | 46 (0%) |
| Eye | CPT: 66984–66,983, cataract surgery w/iol 1 stage | 19,995 (13%) | 39 (0%) |
| Genitourinary | CPT: 52214–52,332, cystoscopy and treatment | 13,965 (9%) | 2283 (16%) |
| Genitourinary | CPT: 55700–55,705, biopsy of prostate | 6583 (4%) | 795 (12%) |
| ENT | CPT: 69220–69,222, clean out mastoid cavity | 5128 (3%) | 46 (1%) |
| General Surgery | CPT: 49505–49,507, 49,520–49,525, 49,550–49,553, 49,650–49,651, inguinal hernia repair | 4824 (3%) | 35 (1%) |
| Eye | CPT: 66982, cataract surgery complex | 4761 (3%) | 1 (0%) |
| Eye | CPT: 66821, after cataract laser surgery | 3731 (2%) | 5 (0%) |
| Orthopedic | CPT: 29850–29,886, knee arthroscopy/surgery | 3219 (2%) | 135 (4%) |
| Genitourinary | CPT: 52353, 52,356, cystoureteroscopy w/ lithotripsy | 2357 (2%) | 472 (20%) |
| Genitourinary | CPT: 52204, cystoscopy w/biopsy(s) | 2261 (1%) | 369 (16%) |
| General Surgery | CPT: 47562–47,564, laparoscopic cholecystectomy | 2208 (1%) | 6 (0%) |
| Orthopedic | CPT: 20680–20,670, removal of support implant | 1904 (1%) | 146 (8%) |
| Orthopedic | CPT: 29806–29,825, shoulder arthroscopy/surgery | 1888 (1%) | 27 (1%) |
| Genitourinary | CPT: 51102, drain bl w/cath insertion | 1792 (1%) | 43 (2%) |
| Eye | CPT: 65855, trabeculoplasty laser surgery | 1745 (1%) | 2 (0%) |
| General Surgery | CPT: 49561–49,566, 49,652–49,656, ventral hernia repair | 1634 (1%) | 4 (0%) |
| Eye | CPT: 15823–15,822, 67,880–67,882, 67,961–67,966, revision of eyelid, upper or lower | 1628 (1%) | 64 (4%) |
| ENT | CPT: 31510, 31,535–31,536, 31,576, laryngoscopy w/ biopsy | 1592 (1%) | 45 (3%) |
| Eye | CPT: 66761–66,762, revision of iris | 1493 (1%) | 4 (0%) |
| Eye | CPT: 67800–67,808, 67,840, remove eyelid lesion(s) | 1449 (1%) | 9 (1%) |
| General Surgery | CPT: 49585–49,586, umbilical hernia repair | 1401 (1%) | 3 (0%) |
| ENT | CPT: 38500–38,525, biopsy/removal lymph nodes | 1289 (1%) | 27 (2%) |
| Genitourinary | CPT: 52601, prostatectomy (TURP) | 1283 (1%) | 62 (5%) |
| Orthopedic | CPT: 20220–20,225, bone biopsy trocar/needle | 1003 (1%) | 12 (1%) |
Note, top 25 surgeries represent 74% of total surgeries and 61% of surgeries with prolonged prophylactic antimicrobials in sample
Patient, Procedure and Facility Characteristics Associated with Receiving Prolonged Prophylactic Antimicrobials among 153,097 VA Outpatient Surgeries from FY16–17
| Variables | Unadjusted Model | Adjusted Model |
|---|---|---|
| Facility Characteristics | ||
| Complex HOPD | Ref | Ref |
| ASC | 1 (0.89–1.12) | 1.32 (1.16–1.49) |
| Standard HOPD | 1.51 (1.31–1.74) | 1.34 (1.16–1.55) |
| Intermediate HOPD | 1.67 (1.59–1.77) | 1.74 (1.64–1.85) |
| Patient Characteristics | ||
| Age: 20–60 years | 1.17 (1.07–1.27) | |
| 61–67 years | 1.01 (0.93–1.09) | |
| 68–70 years | 1.09 (1.01–1.19) | |
| 71–76 years | 1.03 (0.94–1.12) | |
| 77–100 years | Ref | |
| Female | 1.2 (1.08–1.34) | |
| White | 1.1 (1.04–1.17) | |
| Procedure Characteristics | ||
| Relative value unit: 0.5–1.4 RVUs | Ref | |
| 1.5–2.8 RVUs | 4.03 (3.47–4.68) | |
| 2.8–6.4 RVUs | 5.83 (5.04–6.75) | |
| 6.5–8.5 RVUs | 6.27 (5.38–7.31) | |
| 8.5–23.5 RVUs | 4.49 (3.83–5.26) | |
| Surgical specialty: Orthopedics | Ref | |
| Eye | 0.15 (0.12–0.17) | |
| Genitourinary | 4.94 (4.51–5.41) | |
| Ear/Nose/Throat | 4.19 (3.79–4.63) | |
| General Surgery | 0.16 (0.13–0.2) | |
| Model Performance | ||
| C-statistic | 0.544 | 0.836 |
| Max likelihood estimate intercept (std. dev) | −3.05 (0.01)*** | −5.31 (0.1)*** |
Note: Insignificant variables (comorbidity score) and temporal effects not reported
***p-value< 0.0001